NCT06896227
TAVR: The Impact of Prothesis Positioning on Valvular and Coronary Hemodynamics
StatusUnknown
PhaseNot applicable
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Presence of a commissural alignment
Timeframe: Day 1
Presence of symmetrical position
Timeframe: Day 1
Transvalvular gradients
Timeframe: baseline + day 1
Effective orifice area (EOA)
Timeframe: baseline + day 1
Doppler velocity index
Timeframe: baseline + day 1
Paravalvular leakage
Timeframe: Day 1
Turbulent flow
Timeframe: baseline + day 1
Pressure recovery
Timeframe: Day 1
Energy loss coefficient
Timeframe: Day 1
global coronary flow reserve
Timeframe: Day 1
Peak velocity
Timeframe: Day 1
Wall sheer stress
Timeframe: Day 1
Flow displacement
Timeframe: Day 1
aortic area
Timeframe: Day 1
volumen
Timeframe: Day 1
LV-Function
Timeframe: baseline + day 1
RV-Function
Timeframe: baseline + day 1
Strain
Timeframe: Day 1
Arms and interventions
TTE, TEE and MRI after TAVROther
Each study patient will undergo transthoracic echocardiography, transesophageal echocardiography, and cardiac magnetic resonance imaging following transcatheter aortic valve replacement.
Diagnostic tests: transthoracic echocardiography
Sites
1 site in 1 country
- Division of Cardiology, Pulmonary Disease and Vascular Medicine at University Hospital DuesseldorfDüsseldorf, Germany